Filomicelles from aromatic diblock copolymers increase paclitaxel-induced tumor cell death and aneuploidy compared with aliphatic copolymers.

AIM In order to improve the delivery of aromatic drugs by micellar assemblies, and particularly by long and flexible filomicelles, aromatic groups were integrated into the hydrophobic block of a degradable diblock copolymer. MATERIALS & METHODS Aromatic filomicelles were formed by self-directed assembly of amphiphilic diblock copolymer PEG-PBCL with suitable block ratios. Worm-like filomicelles with an aromatic core were loaded with a common chemotherapeutic, Paclitaxel, for tests of release as well as effects on cancer cell lines in vitro and in vivo. RESULTS Aromatic filomicelles loaded more Paclitaxel than analogous aliphatic systems. Cell death and aneuploidy of surviving cells (which indicates toxicity) were highest for carcinoma lines treated in vitro with the new filomicelles. Initial tests in vivo also suggest more potent tumor shrinkage. CONCLUSION Flexible filomicelles with an aromatic core form an efficient drug delivery system that leads to higher cell death than previously reported systems, while inducing aneuploidy in surviving cells.

[1]  M. Jayakannan,et al.  Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells. , 2015, Nanoscale.

[2]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[3]  V. Stella,et al.  Degradation of paclitaxel and related compounds in aqueous solutions II: Nonepimerization degradation under neutral to basic pH conditions. , 2008, Journal of pharmaceutical sciences.

[4]  Zhiyuan Zhong,et al.  pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[5]  M Laird Forrest,et al.  Clinical toxicities of nanocarrier systems. , 2008, Advanced drug delivery reviews.

[6]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Dennis E Discher,et al.  Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. , 2009, Molecular pharmaceutics.

[8]  J. Barzin,et al.  Investigation of aqueous stability of taxol in different release media , 2014, Drug development and industrial pharmacy.

[9]  G. Kwon,et al.  Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. , 2008, International journal of pharmaceutics.

[10]  D. Timmons,et al.  High-performance liquid chromatographic assay of taxol. , 1992, Analytical chemistry.

[11]  André E. X. Brown,et al.  Curvature-coupled hydration of Semicrystalline Polymer Amphiphiles yields flexible Worm Micelles but favors rigid Vesicles: polycaprolactone-based block copolymers. , 2010, Macromolecules.

[12]  Kandaswamy Vijayan,et al.  Micelles of Different Morphologies—Advantages of Worm-like Filomicelles of PEO-PCL in Paclitaxel Delivery , 2007, Pharmaceutical Research.

[13]  Sheng Zhong,et al.  Block Copolymer Assembly via Kinetic Control , 2007, Science.

[14]  H. Dvorak,et al.  Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy. , 1990, Progress in clinical and biological research.

[15]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[16]  H. Uludaǧ,et al.  Multifunctional Polymeric Micelles for Enhanced Intracellular Delivery of Doxorubicin to Metastatic Cancer Cells , 2008, Pharmaceutical Research.

[17]  Adam Blanazs,et al.  Self-Assembled Block Copolymer Aggregates: From Micelles to Vesicles and their Biological Applications. , 2009, Macromolecular rapid communications.

[18]  H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[19]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[20]  You Han Bae,et al.  Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[21]  V. Marinković,et al.  Paclitaxel as an anticancer agent: isolation, activity, synthesis and stability , 2011 .

[22]  A. Demain,et al.  Natural products for cancer chemotherapy , 2011, Microbial biotechnology.

[23]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Dennis E Discher,et al.  Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[26]  T. Faunce,et al.  Assessing the Safety and Cost-Effectiveness of Early Nanodrugs , 2009, Journal of law and medicine.

[27]  M. Sansom,et al.  Amino acid distributions in integral membrane protein structures. , 2001, Biochimica et biophysica acta.

[28]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[29]  Leslie Wilson,et al.  βIII-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability* , 2005, Journal of Biological Chemistry.

[30]  G. Z. Cheng,et al.  Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.

[31]  David Pellman,et al.  Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.

[32]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[33]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[34]  V. Labhasetwar,et al.  Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. , 2008, Biomaterials.

[35]  Michael L Klein,et al.  Nanoparticle Shape Improves Delivery: Rational Coarse Grain Molecular Dynamics (rcg-md) of Taxol in Worm-like Peg-pcl Micelles 2 , 2022 .

[36]  Jianbin Tang,et al.  The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.

[37]  Kazunori Kataoka,et al.  Polymeric micelles for nano-scale drug delivery , 2011 .

[38]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[39]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[40]  W. B. Derry,et al.  Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.

[41]  C. Fairchild,et al.  Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. , 1994, Cancer research.

[42]  Michael D. Brooks,et al.  Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. , 2015, Cell stem cell.